SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-062532
Filing Date
2011-11-09
Accepted
2011-11-09 16:06:48
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v238881_10q.htm 10-Q 505476
2 EXHIBIT 31.1 v238881_ex31-1.htm EX-31.1 17216
3 EXHIBIT 31.2 v238881_ex31-2.htm EX-31.2 17517
4 EXHIBIT 32.1 v238881_ex32-1.htm EX-32.1 6959
5 EXHIBIT 32.2 v238881_ex32-2.htm EX-32.2 7715
  Complete submission text file 0001144204-11-062532.txt   1596490

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pip-20110930_pre.xml EX-101.PRE 67008
7 XBRL INSTANCE DOCUMENT pip-20110930.xml EX-101.INS 148214
8 XBRL TAXONOMY EXTENSION SCHEMA pip-20110930.xsd EX-101.SCH 10540
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pip-20110930_cal.xml EX-101.CAL 28834
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pip-20110930_def.xml EX-101.DEF 62120
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pip-20110930_lab.xml EX-101.LAB 68551
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 111191762
SIC: 2834 Pharmaceutical Preparations